Stevens Laboratory - Library of Structures Solved
(last updated 09/07/2007)

2007

2ofz_bio_r_250.jpg

2OFZ

Ultrahigh Resolution Crystal Structure of RNA Binding Domain of SARS Nucleopcapsid (N Protein) at 1.1 Angstrom Resolution in Monoclinic Form.

2og3_bio_r_250.jpg

2OG3

Structure of the rna binding domain of n protein from SARS coronavirus in cubic crystal form

2ozk_bio_r_250.jpg

2OZK

Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS

2006

2acf_bio_r_250.jpg

2ACF

Crystal structure of ADRP domain of SARS NSP3

2fpq_bio_r_250.jpg

2FPQ

Crystal Structure of Botulinum Neurotoxin Type D Light Chain

2fyg_bio_r_250.jpg

2FYG

Crystal structure of NSP10 from Sars coronavirus

2np0_bio_r_250.jpg

2NP0

Crystal structure of the Botulinum neurotoxin type B complexed with synaptotagamin-II ectodomain

2nyy_bio_r_250.jpg

2NYY

Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody CR1

2nz9_bio_r_250.jpg

2NZ9

Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody AR2

2005

1y2m_asym_r_250.jpg

1Y2M

Crystal structure of phenylalanine ammonia-lyase from yeast Rhododporidium toruloides

1ybi_bio_r_250.jpg

1YBI

Crystal structure of HA33A, a neurotoxin-associated protein from Clostridium botulinum type A

1zb7_bio_r_250.jpg

1ZB7

Crystal Structure of Botulinum Neurotoxin Type G Light Chain

2004

1tdw_bio_r_250.jpg

1TDW

Crystal structure of double truncated human phenylalanine hydroxylase BH4-responsive PKU mutant A313T

1tg2_bio_r_250.jpg

1TG2

Crystal structure of phenylalanine hydroxylase A313T mutant with 7,8-dihydrobiopterin bound

1ub5_bio_r_250.jpg

1UB5

Crystal structure of Antibody 19G2 with hapten at 100K

1ub6_asym_r_250.jpg

1UB6

Crystal structure of Antibody 19G2 with sera ligand

1um4_bio_r_250.jpg

1UM4

Catalytic Antibody 21H3 with hapten

1um5_bio_r_250.jpg

1UM5

Catalytic Antibody 21H3 with alcohol substrate

1ub6_asym_r_250.jpg

1UM6

Catalytic antibody 21h3

2003

1n7m_bio_r_250.jpg

1N7M

Germline 7G12 with N-methylmesoporphyrin

1ngw_bio_r_250.jpg

1NGW

Chimeric Affinity Matured Fab 7g12 complexed with mesoporphyrin

1ngx_bio_r_250.jpg

1NGX

Chimeric Germline Fab 7g12 with jeffamine fragment bound

1ngy_bio_r_250.jpg

1NGY

Chimeric Mature Fab 7g12-Apo

1ngz_bio_r_250.jpg

1NGZ

Chimeric Germline Fab 7g12-apo

2002

 1LTU

 Crystal Structure of Chromobacterium Violaceum Phenylalanine Hydroxylase, Apo (No Iron Bound) Structure

 1LTV

 Crystal Structure of Chromobacterium Violaceum Phenylalanine Hydroxylase, Structure has Bound Oxidized Iron (III)

 1LTZ

 Crystal Structure of Chromobacterium Violaceum Phenylalanine Hydroxylase, Structure has Bound Iron (III) and Oxidized Cofactor 7,8-Dihydrobiopterin

1MLW

Crystal Structure of Human Tryptophan Hydroxylase With Bound 7,8-Dihydro-L-Biopterin Cofactor and Fe(III)

1MT5

Crystal Structure of Fatty Acid Amide Hydrolase

 2001

 

 1HTZ

 Crystal Structure of Tem52b-Lactamase

2000 

 

 1C7I

Directed Evolution Thermophylic PNB Esterase 

 

 1C7J

Directed Evolution PNB Esterase 56C8

 

 1E74

NMR Solution Structure of Alpha-Conotoxin IM1 Point Mutation Variant R11E

 

 1E75

NMR Solution Structure of Alpha-Conotoxin IM1 Point Mutation Variant R7L

 

 1E76

NMR Solution Structure of Alpha-Conotoxin IM1 Point Mutation Variant D5N

 

 1F82

Botulinum Neurotoxin Type B Catalytic Domain

 

 1F83

Botulinum Neurotoxin Type B Catalytic Domain with Synaptobrevin II Bound

 

 1FL3

 Blue Fluorescent Antibody 19G2

 1FL5

Unliganded Germline Precursor to the Sulfide Oxidase Catalytic Antibody 28B4

 1FL6

Hapten Complexed Germline Precursor to Sulfide Oxidase Catalytic Antibody 28B4

 1999

1C00 

 Para-Nitrobenzyl Esterase Monomer from Bacillus Subtilis (2.00Å)

 

1D5B

Chimeric Oxy-Cope Catalytic Antibody (Fab Fragment, 2.80Å)

 

1D5I

Chimeric Germline Precursor Of Oxy-Cope Catalytic Antibody Az-28 (Light Chain) (2.00Å)

 

1D6V

 Chimeric Germline Precursor Of Oxy-Cope Catalytic Antibody Az-28 (Heavy Chain) (2.00Å)

 

 1DMW

Crystal Structure of Double Truncated Human Phenylalanine Hydroxylase with Bound 7,8-Dihydro-L-Biopterin

 

 1QE3

 Para-Nitrobenzyl Esterase Monomer from Bacillus Subtilis (1.50Å)

 

 1QE8

 Para-Nitrobenzyl Esterase Monomer from Bacillus Subtilis Mutation: I60V, L144M, P317S, H322R, L334S, M358V, Y370F, P392V, E420G (1.60Å)

 

3FCT

 Metal Chelatase Catalytic Antibody with Hapten
[Chimeric Fab Fragment] (2.40Å)

 1998

 

 1A4J

Diels Alder Catalytic Antibody (2.10Å)

 

 1A4K

Diels Alder Catalytic Antibody with Hapten (2.40Å)

 

 1IM1

a-Conotoxin Im1 by NMR

 

 2PAH

 Tetrameric Human Catalytic and Tetramerization Domains Phenylalanine Hydroxylase [Residues 118-452] (3.10Å)

 

1PHZ 

Rat phenylalanine Hydroxylase Containing the N-terminal Regulatory Domain and the Catalytic Domain (d COOH 430) - Phosphorylated (2.20Å)

 

2PHM

Rat Phenylalanine Hydroxylase Containing the N-terminal Regulatory Domain and the Catalytic Domain (d COOH 430) - Unphosphorylated (2.60Å)

 

3PAH 

Human Phenylalanine Hydroxylase Double Truncated form (d NH 102 - d COOH 428) with Bound Adrenaline Inhibitor (2.00Å)

 

4PAH

Human Phenylalanine Hydroxylase Double Truncated form (d NH 102 - d COOH 428) with Bound Nor-adrenaline Inhibitor (2.00Å)

 

5PAH

Human phenylalanine hydroxylase double truncated form (d NH 102 - d COOH 428) with bound dopamine inhibitor (2.10Å)

 

6PAH

 Human Phenylalanine Hydroxylase Double Truncated form (d NH 102 - d COOH 428) with Bound L-DOPA Inhibitor (2.15Å)

 

 2TOH

Tyrosine 3-Monooxygenase; Catalytic and Tetramerization Domains, Residues 160 - 498; Iron and 7,8-Dihydrobiopterin At The Active Site (2.30Å)

 

 3BTA

Botulinum Neurotoxin Type A, Full Length Toxin (3.20Å)

 1997

 

1AJ7

Catalytic Antibody 48G7 Germline Fab with Hapten (2.10Å)

 

1AXS

 Oxy-Cope Catalytic Antibody
[Chimeric Fab Fragment] (2.60Å)

 

 1PAH

 Phenylalanine Hydroxylase with Ferric Iron At The Active Site (2.00Å)

 

1TOH

 Tyrosine Hydroxylase with Ferric Iron At The Active Site (2.30Å)

 

 2RCS

Apo- Immunoglobulin 48G7 Germline Catalytic Antibody Fab (2.10Å)

 1996

 

1GAF

Chimeric Catalytic Antibody 48G7 Fab, Mature with Hapten
(1.95Å)

 

1HKL

 apo- 48G7 Mature Catalytic Antibody Fab (2.70Å)

 

1KEL

28B4 Catalytic Antibody with Hapten Fab
[Fab Fragment Produced Upon The Digestion Of Full-Length Murine Monoclonal Antibody By Papain] (1.90Å)

 

1KEM

28B4 Catalytic Antibody Fab
[Fab Fragment Produced Upon The Digestion Of Full-Length Murine Monoclonal Antibody By Papain] (2.20Å)

 1992

 

1ACM

 Aspartate Carbamoyltransferase
[(Aspartate Transcarbamylase) Mutant With Arg A 54 (Catalytic Chain) Replaced By Ala and Arg C 54 (Catalytic Chain) Replaced By Ala (R(A)54A, R(C)54A) (R State) (E.C. 2.1.3.2) Complex With N-Phosphonacetyl-L-Aspartate (PALA)] (2.80Å)

 

 2AT2

 Aspartate Transcarbamoylase (E.C. 2.1.3.2) (Aspartate Carbamoyltransferase) (3.00Å)

 1990

 

4AT1

 Aspartate Carbamoyltransferase
[(Aspartate Transcarbamylase) (T State) (E.C. 2.1.3.2) Complex With Adenosine 5-Prime-Triphosphate (ATP)] (2.60Å)

 

5AT1

 Aspartate Carbamoyltransferase
[(Aspartate Transcarbamylase) (T State) (E.C. 2.1.3.2) Complex With Cytidine 5-Prime-Triphosphate (CTP)] (2.60Å)

 

6AT1

 Aspartate Carbamoyltransferase
[(Aspartate Transcarbamylase) (T State) (E.C. 2.1.3.2)] (2.60Å)

 1989

 

7AT1

 Aspartate Carbamoyltransferase
[(Aspartate Transcarbamylase) (R State) (E.C. 2.1.3.2) Complex With Phosphonoacetamide (PAM), Malonate (MAL), and Adenosine 5-Prime-Triphosphate (ATP)] (2.80Å)

 

8AT1 

 Aspartate Carbamoyltransferase
[(Aspartate Transcarbamylase) (R State) (E.C. 2.1.3.2) Complex With Phosphonoacetamide (PAM), Malonate (MAL), and Cytidine 5-Prime-Triphosphate (CTP)] (2.80Å)

 

-->